DRTS Reports 100% Local Disease Control in Pancreatic Cancer Trials, 27% Device Adverse Events, EUS Integration, First DDW 2026 Presentation
Alpha Tau Medical Ltd. Ordinary Shares · Now $9.66
+28% in 7d after detection
Post-detection moves
1h
—
1d
-1.9%
3d
+4.2%
7d
+28%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS